We are live on
!
Find out more
LS
Leelyn Smith Portfolio holdings
AUM
$822M
Turnover
11.52%
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+7.63%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$374M
AUM Growth
+$28.5M
(+8.3%)
Cap. Flow
+$4.55M
Cap. Flow
% of AUM
1.22%
Top 10 Holdings %
Top 10 Hldgs %
43.67%
Holding
421
New
54
Increased
88
Reduced
93
Closed
27
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amplify BlackSwan Growth & Treasure Core ETF
SWAN
|
+$2.82M |
| 2 |
Medtronic
MDT
|
+$2.43M |
| 3 |
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
|
+$1.11M |
| 4 |
First Trust Natural Gas ETF
FCG
|
+$479K |
| 5 |
First Trust Energy AlphaDEX Fund
FXN
|
+$471K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$2.73M |
| 2 |
Janus Henderson Short Duration Income ETF
VNLA
|
+$695K |
| 3 |
Invesco Total Return Bond ETF
GTO
|
+$514K |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$492K |
| 5 |
First Trust NASDAQ-100 Technology Index Fund
QTEC
|
+$441K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.83% |
| 2 | Technology | 10.65% |
| 3 | Healthcare | 8.05% |
| 4 | Consumer Discretionary | 7.12% |
| 5 | Financials | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
JPMorgan BetaBuilders Japan ETF
BBJP
$19.2B
| $2K | ﹤0.01% |
+40
| New | +$2.28K |
2021 Q4
0 quarters
|
|
352
Cigna
CI
$79B
| $2K | ﹤0.01% |
10
| – | – |
2019 Q4
8 quarters
|
|
353
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.4B
| $2K | ﹤0.01% |
+32
| New | +$2.44K |
2021 Q4
0 quarters
|
|
354
iShare MSCI Eurozone ETF
EZU
$9.26B
| $2K | ﹤0.01% |
+43
| New | +$2.12K |
2021 Q4
0 quarters
|
|
355
General Motors
GM
$73.4B
| $2K | ﹤0.01% |
30
+10
| +50% | +$584 |
2021 Q1
3 quarters
|
|
356
Halliburton
HAL
$27.4B
| $2K | ﹤0.01% |
70
| – | – |
2020 Q4
4 quarters
|
|
357
iShares Core S&P US Growth ETF
IUSG
$34B
| $2K | ﹤0.01% |
+18
| New | +$2.01K |
2021 Q4
0 quarters
|
|
358
Johnson Controls International
JCI
$89.4B
| $2K | ﹤0.01% |
24
| – | – |
2020 Q4
4 quarters
|
|
359
Kopin
KOPN
$688M
| $2K | ﹤0.01% |
455
| – | – |
2021 Q1
3 quarters
|
|
360
Lumen Technologies, Inc. Common Stock
LUMN
$5.02B
| $2K | ﹤0.01% |
+183
| New | +$2.33K |
2021 Q4
0 quarters
|
|
361
Simplify Volatility Premium ETF
SVOL
$527M
| $2K | ﹤0.01% |
77
+3
| +4% | +$82 |
2021 Q3
1 quarter
|
|
362
Wrap Technologies
WRAP
$84M
| $2K | ﹤0.01% |
500
| – | – |
2020 Q4
4 quarters
|
|
363
DELISTED
Nikola Corporation Common Stock
NKLA
| $2K | ﹤0.01% |
+7
| New | +$2.33K |
2021 Q4
0 quarters
|
|
364
DELISTED
Avanos Medical
AVNS
| $1K | ﹤0.01% |
32
| – | – |
2019 Q4
8 quarters
|
|
365
JPMorgan BetaBuilders Canada ETF
BBCA
$11.4B
| $1K | ﹤0.01% |
+20
| New | +$1.34K |
2021 Q4
0 quarters
|
|
366
Citigroup
C
$207B
| $1K | ﹤0.01% |
10
| – | – |
2019 Q4
8 quarters
|
|
367
DELISTED
ChampionX
CHX
| $1K | ﹤0.01% |
50
| – | – |
2020 Q4
4 quarters
|
|
368
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.1B
| $1K | ﹤0.01% |
11
| – | – |
2020 Q4
4 quarters
|
|
369
iShares Biotechnology ETF
IBB
$10.6B
| $1K | ﹤0.01% |
+8
| New | +$1.24K |
2021 Q4
0 quarters
|
|
370
Jumia Technologies
JMIA
$816M
| $1K | ﹤0.01% |
76
| – | – |
2021 Q1
3 quarters
|
|
371
Lumentum
LITE
$78.8B
| $1K | ﹤0.01% |
+10
| New | +$910 |
2021 Q4
0 quarters
|
|
372
Sylvamo
SLVM
$1.29B
| $1K | ﹤0.01% |
+47
| New | +$1.37K |
2021 Q4
0 quarters
|
|
373
TSMC
TSM
$2.19T
| $1K | ﹤0.01% |
+10
| New | +$1.17K |
2021 Q4
0 quarters
|
|
374
State Street SPDR S&P Biotech ETF
XBI
$9.9B
| $1K | ﹤0.01% |
+10
| New | +$1.21K |
2021 Q4
0 quarters
|
|
|
FMBI
375
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $1K | ﹤0.01% |
+72
| New | +$1.44K |
2021 Q4
0 quarters
|
|
Similar funds
SCM
SCP
GSWM
HVIA
MGAM
IA
WRPWM
RP
Leelyn Smith's Q4 2021 Portfolio in Review
As of Q4 2021, Leelyn Smith held 421 positions worth $374M, up 8.3% from $345M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Leelyn Smith's Q4 2021 filing shows 54 new, 88 increased, 93 reduced and 27 closed positions. Its largest new stake was First Trust Natural Gas ETF: 26,699 shares worth $459K. The largest sale was Stryker, an estimated $2.73M.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 53% a quarter earlier, followed by Technology and Healthcare.
- Leelyn Smith's largest Q4 2021 buy was First Trust Natural Gas ETF: 26,699 shares worth $459K.
- Leelyn Smith added most to Amplify BlackSwan Growth & Treasure Core ETF in Q4 2021, an estimated $2.82M increase.
- Leelyn Smith's biggest Q4 2021 reduction was Stryker, cutting an estimated $2.73M.
- Leelyn Smith fully exited First Trust NASDAQ-100 Technology Index Fund in Q4 2021, selling an estimated $441K.
- Leelyn Smith's ten largest holdings make up 44% of its $374M portfolio in Q4 2021.
- Leelyn Smith opened 54 new positions and closed 27 in Q4 2021.
- Leelyn Smith's portfolio value rose 8.3% quarter-over-quarter to $374M.
Based on Leelyn Smith's 13F filing for Q4 2021, filed 14 Feb 2022.